Genetics of familial and sporadic Alzheimer s disease

Piaceri, Irene·2013·Frontiers in Bioscience

Cited by (256)

Items 101–200 of 256

  1. Platelets in Amyloidogenic Mice Are Activated and Invade the Brain
    Kathrin Maria Kniewallner, Diana M Bessa de Sousa, Michael Stefan Unger, Heike Mrowetz, Ludwig Aigner · 2020 · Frontiers in Neuroscience
  2. The Mechanistic Role of Bridging Integrator 1 (BIN1) in Alzheimer’s Disease
    Pei-Rong Gao, Lingqi Ye, Hong-Rong Cheng, Honglei Li · 2020 · Cellular and Molecular Neurobiology
  3. The Potential Roles of Redox Enzymes in Alzheimer’s Disease: Focus on Thioredoxin
    Jing Jia, Xiansi Zeng, Guangtao Xu, Zhanqi Wang · 2021 · ASN NEURO
  4. Strategies to gain novel Alzheimer’s disease diagnostics and therapeutics using modulators of ABCA transporters
    Jens Pahnke, Pablo Bascuñana, Mirjam Brackhan, Katja Stefan, Vigneshwaran Namasivayam, Radosveta P. Koldamova, Jingyun Wu, Luisa Möhle, Sven Marcel Stefan · 2021 · Free Neuropathology
  5. An Alzheimer’s Disease Patient-Derived Olfactory Stem Cell Model Identifies Gene Expression Changes Associated with Cognition
    Laura M. Rantanen, Mainá Bitar, Riikka Lampinen, Romal Stewart, Hazel Quek, Lotta E. Oikari, Carla Cuní‐López, Ratneswary Sutharsan, Gayathri Thillaiyampalam, Jamila Iqbal et al. · 2022 · Cells
  6. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer’s disease
    H. Marei, Muhammad Umar Aslam Khan, Anwarul Hasan · 2023 · Cellular & Molecular Biology Letters
  7. Integration of Machine Learning Methods to Dissect Genetically Imputed Transcriptomic Profiles in Alzheimer’s Disease
    Carlo Maj, Tiago Azevedo, Valentina Giansanti, Oleg Borisov, Giovanna Maria Dimitri, Simeon Spasov, Alzheimer’s Disease Neuroimaging Initiative, Píetro Lió, Ivan Merelli · 2019 · Frontiers in Genetics
  8. The mitochondrial O-linked N-acetylglucosamine transferase (mOGT) in the diabetic patient could be the initial trigger to develop Alzheimer disease
    Liliana Lozano, Roberto Lara‐Lemus, Edgar Zenteno, Noé Alvarado‐Vásquez · 2014 · Experimental Gerontology
  9. The Role of PGRN in Alzheimer’s Disease
    Hua Jing, Meng‐Shan Tan, Jin‐Tai Yu, Lan Tan · 2015 · Molecular Neurobiology
  10. Animal Models of Alzheimer’s Disease
    Morgan Newman, Doris Kretzschmar, Imran Khan, Mengqi Chen, Giuseppe Verdile, Michael T. Lardelli · 2017 · Elsevier eBooks
  11. The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer’s Disease Modeling
    Christopher Lee, Stephanie Michelle Willerth, Haakon B. Nygaard · 2020 · Progress in Neurobiology
  12. Effect of Chronic Stress Present in Fibroblasts Derived from Patients with a Sporadic Form of AD on Mitochondrial Function and Mitochondrial Turnover
    Karolina Drabik, Dominika Malińska, Karolina Piecyk, Grażyna Dębska–Vielhaber, Stefan Vielhaber, Jerzy Duszyński, Joanna Szczepanowska · 2021 · Antioxidants
  13. Neurodegenerative diseases in a dish: the promise of iPSC technology in disease modeling and therapeutic discovery
    Yongzhi Xie, R.X. Zhang · 2014 · Neurological Sciences
  14. Binding mode analysis of ABCA7 for the prediction of novel Alzheimer's disease therapeutics
    Vigneshwaran Namasivayam, Katja Stefan, Jens Pahnke, Sven Marcel Stefan · 2021 · Computational and Structural Biotechnology Journal
  15. Titanium dioxide and carbon black nanoparticles disrupt neuronal homeostasis via excessive activation of cellular prion protein signaling
    Luiz W. Ribeiro, Mathéa Pietri, Héctor Ardila-Osorio, Anne Baudry, François Boudet-Devaud, Chloé Bizingre, Zaira E. Arellano-Anaya, Anne‐Marie Haeberlé, Nicolas Gadot, Sonja Boland et al. · 2022 · Particle and Fibre Toxicology
  16. An Insight in Pathophysiological Mechanism of Alzheimer’s Disease and its Management Using Plant Natural Products
    Zeba Firdaus, Tryambak Deo Singh · 2020 · Mini-Reviews in Medicinal Chemistry
  17. Imaging Methods Applicable in the Diagnostics of Alzheimer’s Disease, Considering the Involvement of Insulin Resistance
    Petra Hnilicová, Ema Kantorová, Stanislav Šutovský, Milan Grofik, Kamil Zeleňák, Egon Kurča, Norbert Žilka, Petra Parvanovova, Martin Kolísek · 2023 · International Journal of Molecular Sciences
  18. Untold New Beginnings: Adult Hippocampal Neurogenesis and Alzheimer’s Disease
    Cátia M. Teixeira, Noemí Pallas‐Bazarra, Marta Bolós, Julia Terreros‐Roncal, Jesús Ávila, Marı́a Llorens-Martı́n · 2018 · Journal of Alzheimer s Disease
  19. Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing
    Ginevra Nannelli, Marina Ziche, Sandra Donnini, Lucia Morbidelli · 2020 · Biomedicines
  20. Mutations modifying sporadic Alzheimer’s disease age of onset
    Vélez, Jorge I., Lopera, Francisco, Patel, Hardip R., Johar, Angad S., Cai, Yeping, Rivera, Dora, Tobón, Carlos, Villegas, Andrés, Sepulveda‐Falla, Diego, Lehmann, Shaun G. et al. · 2016 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
  21. Modeling of Neurodegenerative Diseases: ‘Step by Step’ and ‘Network’ Organization of the Complexes of Model Systems
    Viacheslav Igorevich Pasko, Aleksandra Sergeevna Churkina, Anton Sergeevich Shakhov, Anatoly A. Kotlobay, Irina Borisovna Alieva · 2022 · International Journal of Molecular Sciences
  22. Extracellular Vesicles, Cell-Penetrating Peptides and miRNAs as Future Novel Therapeutic Interventions for Parkinson’s and Alzheimer’s Disease
    Cameron Noah Keighron, Sahar Avazzadeh, Katarzyna Goljanek‐Whysall, Brian McDonagh, Linda Howard, Thomas Ritter, Leo R. Quinlan · 2023 · Biomedicines
  23. Diagnosis of Dementia in the Specialist Setting: A Comparison Between the Swedish Dementia Registry (SveDem) and the Registry of Dementias of Girona (ReDeGi)
    Josep Garre‐Olmo, Sara Garcia Ptacek, Laia Calvó‐Perxas, Oriol Turró Garriga, Secundino López Pousa, Maria Eriksdotter · 2016 · Journal of Alzheimer s Disease
  24. Palonosetron/Methyllycaconitine Deactivate Hippocampal Microglia 1, Inflammasome Assembly and Pyroptosis to Enhance Cognition in a Novel Model of Neuroinflammation
    Reem A. Mohamed, Dalaal M. Abdallah, Amany I. El-Brairy, Kawkab A. Ahmed, Hanan Salah El-Abhar · 2021 · Molecules
  25. Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease
    Cecilia Villegas, Rebeca Perez, Lyvia Lintzmaier Petiz, Talita Glaser, Henning Ulrich, Cristian Paz · 2022 · IUBMB Life
  26. The modeling of Alzheimer's disease by the overexpression of mutant Presenilin 1 in human embryonic stem cells
    Makoto Honda, Itsunari Minami, Norie Tooi, Nobuhiro Morone, Hisae Nishioka, Kengo Uemura, Ayae Kinoshita, John E. Heuser, Norio Nakatsuji, Kazuhiro Aiba · 2015 · Biochemical and Biophysical Research Communications
  27. Mutant Presenilin 1 Dysregulates Exosomal Proteome Cargo Produced by Human-Induced Pluripotent Stem Cell Neurons
    Sonia Podvin, Alexander Curtis Jones, Qing Liu, Brent D. Aulston, Charles Mosier, Janneca Ames, Charisse N. Winston, Christopher B. Lietz, Zhenze Jiang, Anthony John O’Donoghue et al. · 2021 · ACS Omega
  28. Neuroprotective Effects of Tripeptides—Epigenetic Regulators in Mouse Model of Alzheimer’s Disease
    Vladimir Kh. Khavinson, Anastasiia Ilina, Nina Kraskovskaya, Natalia Sergeevna Linkova, Н. В. Колчина, Ekaterina Sergeevna Mironova, Alexander Erofeev, Michael Petukhov · 2021 · Pharmaceuticals
  29. P-Glycoprotein Altered Expression in Alzheimer's Disease: Regional Anatomic Variability
    Brian Jeynes, John Provias · 2013 · Journal of Neurodegenerative Diseases
  30. Model scenarios for cell cycle re-entry in Alzheimer's disease
    Nishtha Pandey, Palakkad Krishnan Unni Vinod · 2022 · iScience
  31. NeuroTransDB: highly curated and structured transcriptomic metadata for neurodegenerative diseases
    Shweta Bagewadi, Subash Adhikari, Anjani Dhrangadhariya, Afroza Khanam Irin, Christian Ebeling, Aishwarya Alex Namasivayam, Matthew Page, Martin Hofmann‐Apitius, Philipp Senger · 2015 · Database
  32. Rab21, a Novel PS1 Interactor, Regulates γ-Secretase Activity via PS1 Subcellular Distribution
    Zhenzhen Sun, Yujie Xie, Yintong Chen, Qinghu Yang, Zhenzhen Quan, Rongji Dai, Hong Qing · 2017 · Molecular Neurobiology
  33. Management of Alzheimers Disease: Role of Existing Therapies, Traditional Medicines and New Treatment Targets
    Harshad Malve · 2017 · Indian Journal of Pharmaceutical Sciences
  34. Unveiling exosomal biomarkers in neurodegenerative diseases: LC-MS-based profiling
    Yan-long Bi, Liang Wang, Chunyan Li, Zhiying Jenny Shan, Lanrong Bi · 2025 · Extracellular Vesicle
  35. Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease?
    Kee-Chan Ahn, Cameron R. Learman, Glen B. Baker, Charles L. Weaver, Phil‐Sang Chung, Hyunggun Kim, Mee-Sook Song · 2019 · Journal of Korean Medical Science
  36. Proteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer’s Disease
    Yanuar Alan Sulistio, Klaus Heese · 2015 · Evidence-based Complementary and Alternative Medicine
  37. Deciphering the Morphological Difference of Amyloid-β Fibrils in Familial and Sporadic Alzheimer’s Diseases
    Gangtong Huang, Zhiyuan Song, Yun Xu, Yunxiang Sun, Feng Ding · 2024 · Journal of Chemical Information and Modeling
  38. Mitochondrial genome mutations and neuronal dysfunction of induced pluripotent stem cells derived from patients with Alzheimer's disease
    Yeonmi Lee, Min‐Chul Kim, Miju Lee, Seongjun So, Soon-Suk Kang, Jiwan Choi, Deokhoon Kim, Hyohoon Heo, Sung Soo Lee, Hee Ra Park et al. · 2022 · Cell Proliferation
  39. Rodent models of Alzheimer's disease: Critical analysis of current hypotheses and pathways for future research
    Pasindu Hansana Singhaarachchi, Péter Antal, Frédéric Calon, Carsten Culmsee, Jean-Christophe Delpech, Martin Feldotto, Jorine Geertsema, Emmy E. Hoeksema, Anikó Kőrösi, Sophie Layé et al. · 2025 · Progress in Neurobiology
  40. Serotonin-mediated regulation of mitophagy in Alzheimer's disease: Mechanistic insights and therapeutic potential
    Omme Fatema Sultana, Madhuri Bandaru, Mst Anika Bushra, P. Hemachandra Reddy, Arubala P. Reddy · 2025 · Ageing Research Reviews
  41. Age, sex, and apolipoprotein E isoform alter contextual fear learning, neuronal activation, and baseline DNA damage in the hippocampus
    Sydney Weber Boutros, Benjamin Zimmerman, Sydney C. Nagy, Vivek K. Unni, Jacob Raber · 2023 · Molecular Psychiatry
  42. The role of ATP‐binding cassette transporter G1 (ABCG1) in Alzheimer's disease: A review of the mechanisms
    Mohsen Karbasi Yazdi, Mohaddeseh Sadat Alavi, Ali Roohbakhsh · 2024 · Basic & Clinical Pharmacology & Toxicology
  43. Advances and Challenges in Gene Therapy for Alzheimer’s Disease
    Fabiana Morroni, Antonella Caccamo · 2024 · Journal of Alzheimer s Disease
  44. A Comprehensive Machine Learning Framework for the Exact Prediction of the Age of Onset in Familial and Sporadic Alzheimer’s Disease
    Jorge Ivan Velez, Luiggi A. Samper, Mauricio Arcos-Holzinger, Lady G. Espinosa, Mario A. Isaza-Ruget, Francisco Javier Lopera, Mauricio Arcos‐Burgos · 2021 · Diagnostics
  45. RNAi mediated silencing of cyclin-dependent kinases of G1 phase slows down the cell-cycle progression and reduces apoptosis
    Małgorzata Sierant, Danuta Piotrzkowska, Barbara Nawrot · 2015 · Acta Neurobiologiae Experimentalis
  46. Centella asiatica, an Ayurvedic Medicinal Plant, Prevents the Major Neurodegenerative and Neurotoxic Mechanisms Associated with Cognitive Impairment
    Manuj Ahuja, Mansi Patel, Mohammed Majrashi, Vanisree Mulabagal, Muralikrishnan Dhanasekaran · 2017 · Medicinal and aromatic plants of the world
  47. Les perturbateurs thyroïdiens et leurs conséquences sur le développement cérébral
    Jean‐Baptiste Fini, BARBARA A. DEMENEIX · 2019 · Biologie Aujourd hui
  48. Critical Review of the Alzheimer’s Disease Non-Transgenic Models: Can They Contribute to Disease Treatment?
    Julio A. Flores-Cuadra, Alanna Madrid, Patricia L. Fernández, Ambar R. Perez-Lao, Diana C. Oviedo, Gabrielle B. Britton, María B. Carreira · 2020 · Journal of Alzheimer s Disease
  49. Alzheimer’s Disease: Current and Future Treatments. A Review
    Evelyn Chou · 2014 · International Journal of Medical Students
  50. Aberrant Dopamine System Function in the Ferrous Amyloid Buthionine (FAB) Rat Model of Alzheimer’s Disease
    Stephanie M. Perez, Angela M. Boley, Alexandra M. McCoy, Daniel J. Lodge · 2023 · International Journal of Molecular Sciences
  51. Alzheimer’s disease and clinical trials
    Deepraj Paul, Rohini Agrawal, Swati Singh · 2024 · Journal of Basic and Clinical Physiology and Pharmacology
  52. β-Amyloid Orchestrates Factor XII and Platelet Activation Leading to Endothelial Dysfunction and Abnormal Fibrinolysis in Alzheimer Disease
    Karen A. García-Mejía, Santiago J. Custodio-Chablé, José E. Vázquez-Franco, Elba Reyes‐Maldonado, Ruth Angélica Lezama · 2021 · Alzheimer Disease & Associated Disorders
  53. Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease
    Vasileios Siokas, Polyxeni Stamati, Georgia Pateraki, Ioannis Liampas, Athina‐Maria Aloizou, Daniil Tsirelis, Αναστασία Νούσια, Markos N. Sgantzos, Grigorios Nasios, Dimitrios Petrou Bogdanos et al. · 2022 · Current Issues in Molecular Biology
  54. Evaluation of Spatial Memory Impairment after Intracerebroventricular Streptozocin Injection in Adult Rats
    Elham Mohammadzadeh, Fatemeh Alipour, Behzad Khallaghi · 2014 · The Neuroscience Journal of Shefaye Khatam
  55. iPSCs as a major opportunity to understand and cure age-related diseases
    Camille Lemey, O. Milhavet, Jean-Marc Lemaître · 2015 · Biogerontology (Dordrecht)
  56. Network pharmacology to elucidate the role of phytotherapy in neurocognitive disorders
    Stefan Barth, Thomas Efferth · 2025 · Phytomedicine
  57. A Novel Single Nucleotide T980C Polymorphism in the Human Carboxypeptidase E Gene Results in Loss of Neuroprotective Function
    Lin Cong, Yong Cheng, Niamh X. Cawley, Saravana R. K. Murthy, Y. Peng Loh · 2017 · PLoS ONE
  58. In silico Characterization of Predominant Genes Involved in Early Onset of Alzheimer's Disease
    Punya Sachdeva, Faizan Ahmad · 2021 · The Journal of Neurobehavioral Sciences
  59. Incomplete penetrance in familial Alzheimer’s disease with PSEN1 Ala260Gly mutation
    Irene Piaceri, Annalisa Chiari, C. Galli, Silvia Bagnoli, Camilla Ferrari, Sharon Trujillo Saavedra, Maria Angela Molinari, Giulia Vinceti, Sandro Sorbi, Benedetta Nacmias · 2020 · Neurological Sciences
  60. Advances in Imaging–Genetic Relationships for Alzheimer's Disease: Clinical Implications
    Silvia Bagnoli, Irene Piaceri, Sandro Sorbi, Benedetta Nacmias · 2014 · Neurodegenerative Disease Management
  61. Plasma extracellular vesicles from <i>APOE3</i> Christchurch carriers display a protective phenotype in early stages of autosomal dominant Alzheimer's disease
    Pineda‐Lopez, Lina, Aguillon, David, Villar‐Vesga, Juan, Valderrama‐Carmona, Pablo, Guerrero, Alejandro, Upreti, Anil, Arevalo‐Alquichire, Said, Correa, Laura, Mendez‐Castellanos, Karin, Castaño, Diana et al. · 2026 · Alzheimer's &amp; Dementia
  62. Mitochondrial Quality Control in Alzheimer’s Disease: Insights from Caenorhabditis elegans Models
    Upasana Ganguly, Trae Carroll, Keith W. Nehrke, Gail V.W. Johnson · 2024 · Antioxidants
  63. A Comprehensive Review on Preclinical Alzheimer's Disease Models: Evaluating their Clinical Relevance
    Virendra Kushwaha, Kantrol Kumar Sahu · 2024 · Current Pharmaceutical Biotechnology
  64. Differential Expression of Neurodegeneration-Related Genes in SH-SY5Y Neuroblastoma Cells Under the Influence of Cyclophilin A: Could the Enzyme be a Likely Trigger and Therapeutic Target for Alzheimer’s Disease?
    Somayeh Pashaei, Sasan Shabani, Soheila Mohammadi, Ludmilla A. Morozova‐Roche, Nader Salari, Zohreh Rahimi, Reza Khodarahmi‬ · 2024 · Neurochemical Research
  65. Early plasma ceramide and sphingomyelin levels reflect APOE genotype but not familial Alzheimer's disease gene mutations in female 5xFAD mice, with brain-region specific sphingolipid alterations
    Daan van Kruining, Mario H. Losen, Jonas Dehairs, Johannes V. Swinnen, Etienne Waelkens, Maarten Honing, Pilar Martínez‐Martínez · 2025 · Neurobiology of Disease
  66. Recent Advances and Future Directions in Alzheimer’s Disease Genetic Research
    Mikaela Stancheva, Draga I. Toncheva, Sena Karachanak-Yankova · 2025 · International Journal of Molecular Sciences
  67. A 3D-induced pluripotent stem cell-derived human neural culture model to study certain molecular and biochemical aspects of Alzheimer’s disease
    Preeti Prasannan, Elodie J. Siney, Shreyasi Chatterjee, David Annandale Johnston, Mohammad Shah, Amritpal K. Mudher, Sandrine Willaime‐Morawek · 2022 · In vitro models
  68. Analysis of genetic mechanisms, clinical characteristics and pathological changes in familial Alzheimer’s disease and sporadic Alzheimer’s disease
    Jiaju Deng, Xing Gao · 2024 · BIO Web of Conferences
  69. Modeling Alzheimer's disease using cerebral organoids: Current challenges and prospects
    Ayodeji Zabdiel Abijo, S Olatunji, Stephen Taiye Adelodun, Moses Oluwasegun Asamu, Noah Adavize Omeiza · 2024 · Brain Organoid and Systems Neuroscience Journal
  70. Brain stem hemorrhage due to cerebral amyloid angiopathy: The autopsy of a patient with Alzheimer’s disease at a young age
    Seiji Ohtani, Keiko Shimizu, Masaru Asari, Chikatoshi Maseda, Kumiko Oka, Hiromi Yamada, Chisato Hoshina, Hiroki Doi, Daisuke Yajima, Hiroshi Shiono et al. · 2014 · Legal Medicine
  71. Novel presenilin 1 mutation (Ile408Thr) in an Italian family with late-onset Alzheimer’s disease
    Andrea Tedde, Antonella Bartoli, Irene Piaceri, Sara Ferrara, Silvia Bagnoli, Antonio Serio, Sandro Sorbi, Benedetta Nacmias · 2015 · Neuroscience Letters
  72. Sex differences in sleep fragmentation in 5xFAD mice
    Kaitlyn Kim, Angel-Rose Villegas, Amanda Kelley, Edwin M. Labut, Tory M. Hagen, Kathy Ruth Magnusson, Heidi E. Kloefkorn · 2025 · Neuroscience
  73. Alzheimer's disease: Current therapeutic strategies and emerging perspectives for multifactorial intervention
    Júlia Gabriela de Melo Silva, Wellinghton de Medeiros Barros, Nathasha Prado-Lopes, Paula Maria Quaglio Bellozi · 2026 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  74. Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer’s disease
    Sepehr Golriz Khatami, Yasamin Salimi, Martin Hofmann‐Apitius, Neil P. Oxtoby, Colin J. Birkenbihl, Alzheimer’s Disease Neuroimaging Initiative, the Japanese Alzheimer’s Disease Neuroimaging Initiative, the Alzheimer’s Disease Repository Without Borders Investigators · 2022 · Alzheimer s Research & Therapy
  75. Interacting Models of Amyloid-β and Tau Proteins: An Approach to Identify Drug Targets in Alzheimer’s Disease
    Priya Khadgawat, Jalahalli Mariswamy Siddesha, Dharini Shashank, K. Prasad Shashanka · 2021 · Journal of Alzheimer s Disease Reports
  76. Live-Cell Imaging of Single Neurotrophin Receptor Molecules on Human Neurons in Alzheimer’s Disease
    Klaudia Barabás, Julianna Kobolák, Soma Godó, Dávid Ernszt, Miklós Kecskés, Csaba Varga, József Kardos, Tibor Zoltán Jánosi, Takahiro K Fujiwara, Akihiro Kusumi et al. · 2021 · International Journal of Molecular Sciences
  77. An Alzheimer’s disease patient-derived olfactory cell model identifies gene expression changes associated with cognition
    Laura M. Rantanen, Mainá Bitar, Riikka Lampinen, Romal Stewart, Hazel Quek, Lotta E. Oikari, Carla Cuní‐López, Ratneswary Sutharsan, Gayathri Thillaiyampalam, Jamila Iqbal et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  78. Specific Role of Extracellular Vesicles in Controlling Neuroinflammation in Alzheimer’s and Parkinson’s Disease: Is an EV-Based Therapy Possible?
    Syamantak Ghosh, Sourav Hom Choudhury, Kamalika Mukherjee, Suvendra N. Bhattacharyya · 2024 · Springer eBooks
  79. Resveratrol Preserves Mitochondrial DNA Integrity and Long-Term Memory without Decreasing Amyloid-β Levels in Alzheimer’s Disease Mouse Models
    Artem P. Gureev, Irina S. Sadovnikova, Ekaterina V. Chernyshova, Ekaterina P. Krutskikh, Irina B. Pevzner, Ljubava D. Zorova, Veronika V. Nesterova, Polina I. Babenkova, Egor Y. Plotnikov · 2025 · Biocell
  80. Role of GSK-3 Inhibition in Alzheimer’s Disease Therapy
    Hala Algazzawi, Jakleen Ziyad Abujamai, Asim Muhammed Alshanberi, Rukhsana Satar, Shakeel Ahmed Ansari · 2025 · Current Alzheimer Research
  81. Investigating the therapeutic potential of pinocembrin in Alzheimer's disease: insights from network pharmacology and molecular docking
    Ashima Sharma, L. Sathiyanarayanan, S. Arulmozhi · 2025 · In Silico Pharmacology
  82. Mesenchymal stem cells and the central nervous system: historical perspectives and future directions
    Christopher Y. Mazurek, Julia K. Kaniuk, Christopher S. Ahuja · 2026 · Frontiers in Molecular Neuroscience
  83. Decoding the secretase puzzle in amyloid-β generation: A state-of-the-art overview of the protease-mediated APP processing cascade in Alzheimer’s disease
    Zuzanna Senkowska, Ewelina Węglarz‐Tomczak · 2026 · Ageing Research Reviews
  84. FDG PET and the genetics of dementia
    Benedetta Nacmias, Valentina Berti, Irene Piaceri, Sandro Sorbi · 2013 · Clinical and Translational Imaging
  85. Mechanisms underlying Alzheimer’s disease
    Anna Maria Bugaj, Natalia Jermakow · 2016 · Neuropsychiatria i Neuropsychologia
  86. Epidemiology of Alzheimer’s disease in the Odesa region
    И. В. Хубетова, D. A. Voloshchuk, K. Kosenko, Yu. M. Vorokhta · 2023 · Zaporozhye Medical Journal
  87. Modifiable chemical risk factors for amyloid-β and Tau protein in Alzheimer’s disease
    Subashchandrabose Chinnathambi, Sneha Malik, Murugappan Kumarappan, Madhura Chandrashekar · 2024 · Advances in protein chemistry and structural biology
  88. Exploring the Role of SMPD3 in the lncRNA-miRNA-mRNA Regulatory Network in TBI Progression by Influencing Energy Metabolism
    Changmeng Cui, Biao Xu, Hui Liu, Changshui Wang, Jia‐Tao Zhang, Pei Jiang, Lei Feng · 2024 · Journal of Inflammation Research
  89. Neurodegenerative Diseases and the Gut Microbiota
    Sílvia Cabré, Kenneth J. O’Riordan, John F. Cryan · 2022 · Progress in inflammation research
  90. Alzheimer’s Disease: An Insightful Review on the Future Trends of the Effective Therapeutics
    Afreen Hashmi, Vivek Srivastava, Syed Abul Kalam, Devesh Kumar Mishra · 2022 · IntechOpen eBooks
  91. Chromium and Alzheimer's disease
    Ansab Akhtar, Sangeeta Pilkhwal Sah · 2023 · Elsevier eBooks
  92. [3H]‐L685,458 Binding Sites are Abundant in Multiple Peripheral Organs in Rats: Implications for Safety Assessment of Putative γ‐Secretase Targeting Drugs
    Zhi-Ying Yang, Jianming Li, Ling Xiao, Lin Mou, Yan Cai, He Huang, Xuegang Luo, Xiao‐Xin Yan · 2014 · Basic & Clinical Pharmacology & Toxicology
  93. Ibuprofen in Prevention of Neurodegenerative Diseases
    Kim Drummond Rainsford · 2015 · Wiley eBooks
  94. Patient-reported characteristics of pernicious anaemia: a first step to initiate James Lind Alliance Priority Setting Partnership driven research
    Alfie Thain, Petra Visser, Kathryn H. Hart, Ebba Nexø, Andrew McCaddon, Luciana Hannibal, Bruce H. R. Wolffenbuttel, Ralph Green, Nicola Ward, Catherine Heidi Seage et al. · 2025 · BMC Family Practice
  95. Alzheimer's disease and suicide association (ASA) theory
    Juliano Flávio Rubatino Rodrigues, Gerardo Maria de Araújo Filho · 2025 · New Ideas in Psychology
  96. iPSC-Derived 3D Brain Organoids as Next-generation Platforms to Study Viral and Toxicant-associated Neurodegeneration
    Md Shahadab, Vaishali Saini, Siddharth Singh, Om Prakash, K. Sachin, Rajan Pandey, Ajay Kumar Meena, H. C. Jha · 2026 · Stem Cell Reviews and Reports
  97. Toward common treatment strategies: convergent proteinopathies and mitochondrial dysfunction in Alzheimer’s and Parkinson’s diseases
    Julie E. V. Offerdahl, Danielle E. Mor · 2026 · Frontiers in Neuroscience
  98. The Risk Factors and Causes for Alzheimer’s Disease
    Youchong Zhang · 2022 · Advances in Social Science, Education and Humanities Research/Advances in social science, education and humanities research
  99. Cardiovascular factors in dementia
    Leszek Bidzan · 2022 · Psychiatria Polska
  100. Cholesterol twists the transmembrane Di-Gly region of amyloid-precursor protein
    David Tzu-Wei Wang, Tiffany Y C Tang, Chun‐Ting Kuo, Yun-Ting Yu, Eric H L Chen, Ming-Tao Lee, Ruei‐Fong Tsai, Hung-Ying Chen, Yun‐Wei Chiang, Rita P.‐Y. Chen · 2023 · PNAS Nexus